LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
5.86
+0.48 (8.92%)
Nov 4, 2024, 4:00 PM EST - Market closed
LENSAR Employees
LENSAR had 130 employees as of December 31, 2023. The number of employees increased by 20 or 18.18% compared to the previous year.
Employees
130
Change (1Y)
20
Growth (1Y)
18.18%
Revenue / Employee
$347,108
Profits / Employee
-$96,600
Market Cap
68.03M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 130 | 20 | 18.18% |
| Dec 31, 2022 | 110 | 0 | - |
| Dec 31, 2021 | 110 | 10 | 10.00% |
| Dec 31, 2020 | 100 | 25 | 33.33% |
| Dec 31, 2019 | 75 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| 111, Inc. | 1,520 |
| Omega Therapeutics | 94 |
| InspireMD | 66 |
| ESSA Pharma | 50 |
| Spero Therapeutics | 46 |
| Forian | 37 |
| Milestone Scientific | 17 |
| Serina Therapeutics | 11 |
LNSR News
- 3 days ago - LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 days ago - LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024 - GlobeNewsWire
- 27 days ago - One Millionth Procedure Completed Using LENSAR's Cataract Laser Systems - GlobeNewsWire
- 2 months ago - LENSAR to Participate in Two Upcoming Investor Conferences - Business Wire
- 3 months ago - LENSAR, Inc. (LNSR) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - LENSAR Reports Second Quarter 2024 Results and Provides Business Update - Business Wire
- 3 months ago - LENSAR Announces Certification for the ALLY® Adaptive Cataract Treatment System in the European Union - Business Wire
- 3 months ago - LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 - Business Wire